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ABSTRACT
An alternative approach to structurefunction analysis of vesicular stomatitis virus (VSV) gene
products and their interactions with one another during each
phase of Ihe viral life cycle is described. We showed previously
by using the vaccinia virus·T7 RNA polymerase expression
system that when cells expressing the nucleocapsid protein (N),
Ihe phosphoprotein (NS), and the large polymerase protein (L)
of VSV were superinfeaed with defective interCering (01)
particles, rapid and efficient replication and amplification of 01
particle RNA occurred. Here, we demonstrate that all five VSV
proteins can be expressed simultaneously when cells are co·
transfected with plasmids containing Ihe matrix protein (M)
gene and Ihe glycoprotein (G) gene of VSV in addition 10
plasmids containing the genes for the N, NS, and L proteins.
When cells coexpressing all five VSV proteins were superinfeded with 01 particles, which because of their defectiveness
are unable to express any viral proteins or to replicate, DI
particle replication, assembly, and budding were observed and
inCectious DI particles were released into the culture nuids.
Omission of either the 1\-1 or G protein expression resnlted in no
01 particle budding. The vector.supported 01 particles were
similar in size and morphology to the authentic DI particles
generated from cells coinfected with 01 particles and helper
VSV and their infectivity could be blocked by anti·VSV or
anti·G antiserum. The successful replication, assembly, and
budding of 01 particles from rells expressing all live VSV
proteins from cloned cDNAs provide a powerful approach for
detailed structure-Cunctlon analysis of the VSV gene products
in each step of the replicative cycle of the virus.

accomplishments hold great promise as experimental systems for genetic manipulation of negative·strand virus genomes. In both cases, however, the success of the system
was closely tied to the biology of the virus. Therefore,
alternative approac hes to study structure-function analysis
of viral proteins would be useful.
Vesicular stomatitis virus (VSV), a rhabdovirus, contains
fi ve structural proteins and each of these proteins plays a role
in replication, asse mbly. and budding ofVSY . The genomic
RNA of VSV is a single-stranded 1l ,161-nucleotide-long
RNA (4, 5) of negative polarity, which is encapsidated with
the nucleocapsid protein (N) as a nucleocapsid structure. The
active te mplate for transcription and replication is the nucleocapsid structure that contains two other minor proteins, the
phosphoprotein (NS) and the large polymerase protein (l ),
both of which are required for the RN A polymerase activity
ofVSV (6-8) . These three proteins-namely, the N, NS, and
l proteins-are the only proteins that are required for
transcription and replication of VSV (8). The ectodomain of
the glycoprotein (G) 'of VSV forms the spikes on the viral
envelope and interacts with virus receptors on susceptible
cells (9). There is evidence that the cytoplasmic domain of the
G protein is required for assembly of VSV (10, 11). Several
lines of evidence indicate that the matrix protein (M) plays a
crucial role in the assembly and budding processes of VSY.
The M protein assembles at the inner surface of the plasma
membrane and is thought to interact with the G protein and
the viral nucleocapsid structures (12-15). The M protein is
also involved in the condensation of nucleocapsids into the
tightly coiled structu res that are found in mature virions (16,

A detailed analysis of the structure and fu nction of negative·
strand RNA virus proteins and their interactions with one
another in the replicative cycle has suffered from the lack of
a method for genetic manipulation. Introduction of site·
directed alterations in genomes of negative·stranded RNA
viruses has been limited because the naked genomic RNA is
not biologically active or infectious. The functional template
for transcription and re plication is the nucleocapsid structure
that contains the genomic RNA encapsidated with nucleo·
capsid protein. Several different approac hes are now avail·
able to generate viral genomic RNAs from cDNA clones in
vitro. However, for negative·strand viruses, these genomic
RNAs must be assembled into nucleocapsid structures to
obtain biological activity. The difficulty in generating biologically ac ti ve nucleocapsids of negative·strand RNA viruses
has provided a major stumbling block for detailed genetic
analysis of this group of viruses. Only recently, synthetic
transcripts representing the genomic RNAs of two negative·
strand RN A viruses. measles and influenza, have been assembled into biologically active nucleocapsids (1-3). These

17).

In this communication, we describe an alternative approach to the study of YSV proteins and their interactions
with each other during replication, asse mbl y, and budd ing of
VSV . We have previously shown that transfection of plasmid
DNAs containing VSV genes under the control ofa 17 RNA
polymerase promoter into cells infected wit h a recombinant
vaccinia virus that contains and expresses the gene for
bacteriophage 17 RNA polymerase results in high-level
expression of the VSV proteins (8). Coexpression of the N,
NS, and L proteins of YSV in cells allows rep lication and
amplification of defective interfering (OJ) particle RNA of
VSV (8) . We and others have also shown that the G and M
proteins can be expressed in fu nctional forms by using the
same expression system (11 , 18-20). We demonstrate here
that by transfecting plasmids containing cDNA clones for all
fi ve of the VSY genes into cells. it is possible to express all
five VSV proteins such that they can support replication,
Abbreviations: VSV . vesicular stomatitis virus: DI. defective interfering; N protein. nucleocapsid protein; NS protein . phosphoprotein;
L protein, large polymel"ll.se protein; M protein. matri~ protein; G
protein, glycoprotein.
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assembly. and budding of infectious DI particles from these
cells. This system will allow us 10 study detailed struclUrefunction aspects of each of the viral proteins and the role of
these proteins in each step of the viral replicative cycle.

MATERIALS AND METHODS
Cell Cultures and Viruses. Baby hamster kidney cells
(B HK-2l) were maintained as monolayer cultures in minimal

essential medium (MEM ) containing 5% heal·inactivated
felal bovine serum and 5% newborn calf serum. VSV (lndi·
ana serOlype. San Juan strain) was propagated in BHK-2 1
cells. Stocks of DI-T particles (21) were prepared as described (8), Recombinant vaccinia virus (vTF7-) containing
the T1 RNA polymerase gene has been described (22) and
was kindly provided by Bernard Moss (National Institutes of
Health , Bethesda, MD). StocksofvTF1-3 were prepared and
infectivity titers were determined as described (8).
PllISmid Vectors and cDNA Clones . The plasmids pAP·N.
pMB-NS , and pAP-L contai ning the N gene, the NS gene,
and the L gene , respectively , have been described (8). The
plasmid pKOM2 containing the wild·type M gene (Indiana
serotype) inserted into the pGEM4XB vector has been described (23) and was kindly provided by Manfred Schubert
(Nalionallnsti tutes of Health). This plasmid contains the M
gene under the control ofTI RN A polymerase promoter. The
plasmid pTF·G contains the VSV G gene (Indiana serotype)
under the conlrol of the TI RNA polymerase promoter and
transcriptional terminator in pTF1-5 (24). This plasmid was
kindly provided by M. Abdul Jabbar (UniveN;ity of California-Los Angeles , Los Angeles). Plasmids were prepared and
purified as described (25).
Virus Infection, DNA Transfection, and Radioactil'e Label·
ing. BHK-2 1 cells in 6()..mm plates were infected with the
recombinant vaccinia virus vTF1·3 and transfected with
plasmid DNA using the calcium phosphate precipitation
method as descri bed (8 . 26). Radioacti ve labeling of proteins
with [l'Slmethionine (20~C i / ml : I Ci = 37 G8q)and of RNA
with IlH]uridine (20 ~Ci / ml) was also performed as detailed
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the VSV N protein were a generous gift rrom D. Lyles (Wake
Forest University. Winston·Salem . NC).

RESULTS
Expression of Viral Proteins in Transrected Cells. We have
previously shown (8) that the N protein. the NS protein , and
the L protein of VSV can be coexpressed in HEp·2 cells by
cotransfection of plasmids containing the individual VSV
genes using the recombinant vaccinia virus-TI RNA pol ymerase expression system (22). The N, NS. and L proteins
expressed in this manner were shown to support replication
orDl particle RNA (8). Here we determined whether all five
VSV protei ns could becoexpressed in cells by cotransfection
of plasmids containing the genes for each or the five VSV
proteins. BHK·21 cell s cotransfected with plasmids contain·
ing the individual VSV genes were labeled with IlsS]methionine. Total cytoplasmic proteins or immunoprecipitated pro·
teins from cytoplasmic extracts were analyzed by SOS/
PAGE . All fi ve VSV proteins were coexpressed in cultures
cotransfected with all five plasmids (Fig. 1. lanes 4 and 7).
The molar ratios or the G. N, and M proteins expressed in
cotransfected cells and that of the proteins present in VSVinfected cells were comparable (lanes 7 and 8). Significant
levels of the Land NS proteins were expressed in cotransfected cells (lanes 3. 4. 6. and 7). However. the amounts of
the Land NS proteins relati ve to other VSV proteins in cells
cotransfected with all fi ve pJasmids were less than that in
VSv ·infected cells (compare lanes 4, 7. and 8) or that in cells
expressing only the N. NS. and L proteins (lanes 3 and 6).
Further experiments have demonstrated that the expression
of the M protein depresses the level of eXpression of other
VSV proteins when coexpressed (unpublished results).
Assembly and Budding of DI Particles (rom Cells Expressing
All Five VSV Proteins. The ability or the five VSV proteins
coexpressed in cells by transfection or plasmids containi ng
each of the fi ve VSV genes to support OJ particle RNA

(8).

Immunoprecipitalion and Electrophoretic Analysis or Pr0teins. Cytoplasmic extracts of cells were prepared and virus·
specific proteins were immunoprecipilaled as described (8)
by using either a mouse pol yclonal antiserum raised against
purified VSV or a monospecific rabbit antibody raised against
an amino-terminal peptide from the L protein (27) kindl y
supplied by Manfred Schubert or both. Proteins were analyzed by electrophoresis in 10% polyacrylamide gels by using
the buffer system of Laemmli (28) and detected by flu orograph y (29).
Analysis of DI Particle RNA Replication . Replication of 01
particle RNA was analyzed by immunoprecipitation of nucleocapsids as described (8). IJHIUridine·labeled RNAs recovered from immunoprecipitated nucleocapsids were resolved by electrophoresis in 1.75% agarose/ citrate/ urea gels
(30) and detected by flu orography (31).
Electron Microscopy. 01 particles generated from cell s
coinfected with helper VSV and 01 particles or from cells
expressing all fi ve VSV proteins were analyzed by transmi s·
sion electron microscopy. Clarified culture fluids were pelleted through a cushion of 5% sucrose in 10 mM Tris·HCI . pH
7.4/ 100 mM NaCI/l mM EOTA (NTE). The pellets were
resuspended in NTE, and aliquots of each sample were
negatively stained with uranyl acelate and visualized by using
a Phillips 301 transmission electron microscope.
Antibodies. Anti·VSV antibodies were raised in mice
against gradient-purified VSV. The monoclonal anti body
(DC3) to the G protein was kindl y provided by Richard
Compans (U niversity of Alabama at Birmingham). The
monoclonal antibodies (1004. 22F9. 19810. and 8CllFIO) to
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FIG. L Coexpression of V5V proteins in cOiransfecled cells.
CeUs infected with vTFI·) and transfeCled with no plasmid (lanes 2
and S). S ~g of pAP·L. 10 ~g of pMB·NS, and IS "g of pAP_N (lanes
) and 6). or S " g of pAP·L. 10 ~g of pMB·NS, IS "g of pAP·N. 10
'" of pKOM2 . and 15 "g of pTF·G (lanes 4 and 7) were labeled with
t)!lSjmelhionine. Total cytoplasmic proteins (lanes 2-4) or proteins
immunopredpitated from cytoplasmic exlracts with anti· VSV antibodies (lanes S-7) were analyzed by SOS/PAGE . Proteins from
mock·infected (lane I) and VSV·infecled (lane 8) cells are also
shown.
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replication, assembly, and budding was examined, The DI
particles cannot replicate on their own because they do not
contain the genetic information to code for any functional
VSV proteins, Normally, coi nfection with helper virus is
required to provide the functional viral proteins for replication, assembly, and budding of the 01 particles, The protocol
to analyze assembly and budding of DI particles from cells
expressing viral proteins is as follows. Cells infected with
vTF7·3 were transfected with various combinations of plasmid ONAs containing the individual genes for the VSV
proteins. At 5 hr after transfection. the cells were superinfecled wilh 01 particles. After virus adsorption, the cells
were washed twice in warm MEM and then incubated al370C
with I ml of MEM. Culture fluids from these cells (passage
1) were collected at 20-24 hr after OJ particle superinfection
and clarified by centrifugation at 16.000 x g for 1 min at4QC.
Half (500 ~I) of the clarified culture fluids was used to infect
(as in passage 1) a second set of cells (passage 2) that had been
infected with vTF7-3 and transfected with the same combi·
nation of plasmid DN As as in the first passage. Culture fluid s
from passage 2 were collected at 20-24 hr after infection and
clarified as above. It was necessary to carry out two passages
to avoid the possible carry-over of any OJ particles used in
the primary infection that may have been present in passage
I culture fluid s due to the release of adsorbed DI particles that
did not penetrate the cells. The presence of infectious 01
particles in the culture fluids from passage 2 cells was assayed
by the RNA replication assay (8) in cells expressing the N.
NS, and L proteins of VSV. After two passages, OJ particles
were not detected in the culture fluids of cells that did not
express any viral proteins (Fig. 2, lane 2) or cells that
expressed only the N, NS, and L proteins (lane 3). Expression of the N, NS, and L proteins in combination with either
the M or G proteins also did not support viral budding (Fig.
2, lanes 4 and 5, respectively) . OJ panicles were detected,
however. in the culture fluids of cells that expressed the M
and G proteins in addition to the N, NS , and L proteins (lane
6). These results show that DI particle budding occurred only
when all five VSV proteins were coexpressed and that the M
and G proteins are required for assembly and budding of
infectious OJ panicles.
To demonstrate that the vector-supported budded 01 par·
ticles were mature particles containing the viral G protein in
the envelope with the nucleocapsids enclosed inside, we tested
antibodies against the G or N protein or against all five VSV
proteins for their ability to block the infectivity of the vectorsupported budded panicles present in the culture fluid s.
Purified authentic 01 panicles or the budded panicles from
culture fluids of cells expressing all five VSV proteins were
treated separately with antibodies raised against VSV, a
monoclonal antibody to the G protein, or a combination offour
monoclonal antibodies to the N protein. The monoclonal
antibody to the G protein neutralizes the infecti vity of VSV
(unpublished result). The monoclonal antibodies to the N
protein are known to bind nucleocapsids (J. Glass and
G.W.W., unpublished observation) and previous work has
shown that such anti-N monoclonal antibodies block the
transcription and replication capabilities of nucleocapsids (32).
The ability of antibody-treated OJ particles and vectorsupported budded particles in the culture fluid s to direct
replication of their genomic RNA was examined in cells that
were infected with helper VSV. The results in Fig. 3 show that
anti-VSV and anti-G antibodies inhibited the genomic RNA
replication of authentic OJ particles used as a control (lanes 2
and 3) as well as Ihat of the DI particles budded into the culture
fluid s of cells expressing all five VSV proteins (lanes 6 and 7).
However, the anti·N antibodies (lanes 4 and 8) had no effe<:t
on infectivity, and RNA replication directed by both types of
01 particles was observed at levels similar to those obtained
in the absence of the antibodies (lanes 1 and 5). Taken
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FIG. 2. ,Assay for the presence of 01 panicles in the culture
fluids . Passage 2 cultu re fluids from cells transfected with no plasmid
(lane 2). 15 ",g ofpAP·N, 10 pog of pMB·NS. and 5 JLg ofpAP·L (1ane
3). 15 ",g of pAP-N. 10 pog of pMB·NS, 5 JLg of pAP·L. and 10 ",g of
pKOM2 (lane 4). 15 pog of pAP-N, 10 pog of pMB·NS, 5 ~g of pAP-L.
and 10 ",g ofpTF·G (lane S), or IS ",g ofpAP·N. 10 ~g of pMB-NS.
5 pog of pAP·L, 10 ",g of pKOM2, and 10 ~g of pTF.G (lane 6) were
analyzed for 01 panicles using an RNA replication assay. The RNA
replication assay was performed by labeling with [JHluridine in cells
that were transfected with 15 ",gofpAP·N, 10 ",8 ofpMB·NS, and
5 ",g of pAP·L plasmid DNA. Labeled RNAs present in immuno·
precipitated nucleocapsids from the cytoplasmic extracts were an·
alyzed in an agarose/urea gel. Lane 1 shows 01 RNA replication
supported by the same system using 500 ",I of 1:500 dilution of
authentic purified 01 stock virus.
together. these results indicate that the particles that are
present in the culture fluids of cells expressing all five VSV
proteins contained G protein on the surface of the envelope
and that the nucleocapsid structures were enclosed within the
envelope in a manner similar to that of the authentic OJ
particles generated from cells coinfected with helper VSV.
The presence of budded OJ particles in culture fluids was
also examined by electron microscopy. The culture fluid s of
cells coinfected with helper VSV and Dl particles contained
a large number of DI particles in addition to some VSV
particles (Fig. 4A). These Dl particles were approximately
one·third of the size of the typical bullet-shaped wild·type
VSV particles and appeared to be spherical. Particles similar
in size and morphology to the authentic 01 particles were also
seen in the culture fluid s of cells eXpressing all five VSV
proteins (arrows in Fig. 48). Culture fluid s of vTF7-3-infected
cells expressing only the N, NS, and L proteins did not
contain any particles similar to authentic OJ particles (data
not shown). The number of particles generated from cells
expressing all five VSV proteins amounted to 5-10% of the
OJ particles generated from helper VSV-coinfected cells.

DISCUSSION
In this report, we demonstrate that cells eXpressing all five
structural proteins of VSV from cloned cON As, when in·
fected with OJ particles. allow replication, assembly, and
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FIG.). Infectivity of 01 particles in the presence of various
antibodies. Purified 01 stock virus or 01 particles present in passage
2 culture fluids from cells transfected with amounts of plasmid ONA
as described in Fig. 2. lane 6. were treated with no antibodies (lanes
1and S), anti-VSV antibody (l:2S dilution; lanes 2 and 6), monoclonal
antibody DC), to the G protein (1:2S dilution; lanes) and 7), or a
combination offour monoclonal antibodies to N protein (l:.50dilution
of each: lanes 4 and 8) for 2 hr at 4"C. The D1 stock virus or culture
fluids were then used in the RNA replication assay in cells infe<:ted
with helper VSV as described (8).
budding of infectious 01 particles. Expression of all five VSV
proteins is absolutely required for 01 panicle assembly and
budding since expression of the N, NS, L, and either the M
or G proteins did not suppon panicle budding. The infectivity
of these particles could be neutralized by anti-VSV and
anti-G antisera but not by anti-N antiserum. indicating that
these particles contained G protein on the envelope with the
nucleocapsid enclosed inside. The panicles were also similar
in size and morphology to the authentic 01 panicles generated from cells coinfected with helper VSV.
Cotransfection with plasmid DNAs containing all fi ve VSV
genes resulted in synthesis of all five VSV proteins. The
molar ratios oftheG, N, and M proteins in cells coexpressing
all five VSV proteins were comparable to those of the cells
infected with VSV. The NS and L proteins, however, were
synthesized in amounts that were less than those seen in
VSV -infected cells. In previous work. we showed that in cells
cotransfected with plasmids bearing the genes for the N. NS,
and L proteins, expression of one protein did not interfere
with the expression of other VSV proteins (8). This. however, was not found to be the case in cells coexpressing all
five VSV proteins. Coexpression of M protein with other
VSV proteins led to inhibition of expression of other VSV
proteins. This result is intriguing, panicularly in the context
of the vaccinia virus TI-RNA polymerase expression system,
since the M protein has been shown to inhibit VSV RNA
transcription by condensing the nucleocapsids into transcriptionally inactive forms (33-35). In VSV-infected cells, VSVspecific proteins are synthesized by polyribosomes in association with the cytoskeletal framework (36) and it has been
postulated that the M protein may disrupt the cytoskeletal
framework (23). It is possible. therefore, that the M protein
inhibits the expression of other VSV proteins at the level of
translation. Further experiments are required to examine the
mechanism of inhibition of protein expression by the M
protein.
We have shown previously that the level of proteins in
transfected cells can be controlled by the amount of DNA
plasmid transfected into the cell. Therefore, it shou ld be

FIG. 4. Electron microscopic analysis of Dl particles. 01 particles isolated and partially purified from culture fluids of cells
coinfected with helper VSV and D1 particles (A) or from cells
transfected with all fivc: plasmids as described in Fig. ) , lanc: 6, and
infected with 01 particles (8) are shown. Arrows in 8 show the
vector·supported budded particles. (Bar '" 200 nm.)
possible to increase the expression of the NS and L proteins
by increasing the amount of the corresponding plasmid DNAs
in transfection such that the molar ratios of all five VSV
proteins are comparable to those seen in VSV-infected cells.
Nevertheless, the levels of proteins synthesized in cells
transfected with all five plasmids under the conditions used
here supported replication , assembly, and budding of DI
particles. DI particle budding from cells expressing all five
VSV proteins was readily detectable using the RNA replication assay and the number of budded particles represented
5-10% of those obtained from helper VSV-coinfected cells.
Using HEp-2 cells, we have shown previously that the
amount ofDl particle RNA replication in cells expressing the
N, NS, and L protei ns is 8-10 times more than that in cells
infected with VSV (8) . However, in BHK-21 cells (used here
because they are stable to long-term vaccinia virus infection)
the amou nt of DI particle RN A replication in cells expressing
the three VSV proteins is less than that in cells infected with
VSV (unpublished observation). The reduced level of vectorsupponed budding of DI particles may be a result of the
reduced level of RNA replication in BHK-21 cells or due to
synthesis of suboptimal levels of the fi ve VSV proteins or
both. The fraction of the cells that express all five VSV
proteins has not been determined yet but this would influence
the number of cells that would support Dl particle budding.
We determined previously that - 40% of the cells in culture
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coexpressed the N, NS, and L proteins when cotransfected
with the corresponding plasmid DNAs (8).
Using the vaccinia virus-T7 RNA polymerase expression
system, Li et al. (19, 20) were able to express the M protein
that could complement a temperature-se nsitive mutant
(ts023) with a defect in the M gene, However, Blondel et al.
(23) were unable to detect stable expression of the M protein
by using a simian virus 40 expression system. The inability to
detect the M protein expression was correlated with rounding
and rapid loss of cells expressing the M protein. When the M
protein was expressed alone or with other VSV proteins, we
did not observe any cell roundi ng or detac hment even at 20
hr after transfection in the experiments described here. It is
hypothesized that the abil ity of M protein to cause cell
rounding and subsequent detachment of cells is antagonized
in vacci nia virus·infected cells.
The ability to generate infectious DI particles from cells
expressing all five VSV proteins provides a way to apply
reverse genetics to VSV . In particular, detai led structurefunction analysis of VSV proteins and their interactions with
each other during RNA replication, assembly, and budding of
virus particles can now be undertaken. The replication system has been used already to analyze the funct ional defects
in temperature-sensitive mutants of VSV with lesions in the
N gene (ref. 37; 1. Glass and G.W.W., Unpublished observations). Additionally, dominant negative deletion mutants
ofNS protein that interfere with the normal fUnctioning of the
wi ld-type NS protein have been identified (ref. 38; M. Howard, A.K.P., and G.W.W., unpublished observations). Studies on the assembly and budding of OJ particles containing
heterologous glycoproteins or chimeras between VSV G
protein and other viral g1ycoproteins shou ld provide information on the mechanisms of generation of viral pseudo·
types. Furthermore, in VSV-infected cells positive- and
negative-strand RNAs are encapsidated but only the nucleocaps ids contain ing the negative-strand RNA are incorporated
into budded virions. The mechanism by which this selection
is exerted is not known at present but can be addressed by
experiments using the system we have described above. Most
importantly, the system we have described above provides
the ability to make specific changes in each of the individual
proteins of VSV and to study the role of the viral proteins in
each step of the replicative cycle of VSV-that is, replication, assembly, and budding. In addition . it is anticipated that
this system should be applicable to other negative-strand
virus systems for which complete cDNA copies of the viral
genes are available.
We thank Dr. L Andrew Ball forcomments and suggestions on the
manuscript. Drs. M. Schubert. and M. A.labbar for providing the
plasmids pKOM2 and pTF·G. respectively. and Dr. K. Anderson for
he lp in preparing the mou se polyclonal antibody against VSV. We
wish to thank Eugene Anns of The University of Alabama at
Birmingham. Comprehensive Cancer Center Electron Microscope
Core Facility. for help in electron microscopy. We also thank Darla
D. Self and Suchitra Pattnaik for excellent preparation of the
manuscript. This work was supported by Public Health Service
Grants Al 20181 and R37 AI 12464 from the National Institutes of
Health.
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